Axiles Bionics

Based in Belgium, Axiles Bionics focuses on innovative prosthetic solutions, enhancing mobility for leg amputees through advanced engineering and design. Axiles Bionics, established in 2018 in Brussels, Belgium, specializes in designing and manufacturing prosthetic feet. The company has completed one significant deal to date. On June 25, 2025, it raised €6 million in a Series A funding round led by PE.

Group, with participation from the European Innovation Council and Finance&Invest. brussels. This funding marks the total amount raised by the company to €6 million. The company was founded by individuals with expertise in bionic technology, contributing to its innovative product line.

Axiles Bionics specializes in advanced prosthetic foot solutions, primarily offering the Lunaris IO and Lunaris Essential. The Lunaris IO is an ankle-foot prosthesis that provides flexibility, comfort, and a natural gait for leg amputees. The Lunaris Essential, inspired by the Lunaris IO, emphasizes simplicity while delivering quality performance, making it an affordable option for users. The company markets its products globally, focusing on regions like Europe, North America, and Asia, where there is a rising demand for mobility solutions for amputees.

Axiles Bionics generates revenue through direct sales of its prosthetic feet to individual consumers and rehabilitation centers. The transaction structure is primarily direct-to-consumer, enhancing user experience and support. Pricing for the Lunaris IO and Lunaris Essential reflects their quality and innovative features. Additionally, partnerships with healthcare providers may expand distribution channels.

The company has secured €6 million in Series A funding to bolster its product offerings and market reach. In June 2025, Axiles Bionics successfully raised €6 million in Series A funding led by PE. Group to support growth initiatives and further bionic technology development. The company is working on upcoming products that will enhance their current offerings.

Plans for market expansion include targeting new regions, although specific markets have yet to be detailed. The funding will be strategically utilized to advance product development and expand market presence.